Adagio Medical details 2026 shareholder vote results
Adagio Medical Holdings, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on June 16, 2026.
Rhea-AI Filing Summary
Adagio Medical Holdings, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on June 16, 2026. Stockholders representing 16,069,984 shares, or 72.35% of the 22,210,459 shares outstanding as of the record date, were present or represented by proxy.
Two director nominees were elected to serve until the 2029 annual meeting. Orly Mishan received 11,930,745 votes for and 1,396,139 withheld, with 2,743,100 broker non-votes. Sean Salmon received 13,322,425 votes for and 4,459 withheld, with 2,743,100 broker non-votes.
Stockholders also ratified the appointment of WithumSmith+Brown, PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, with 16,055,195 votes for, 14,081 against, and 708 abstentions.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
Annual Meeting of Stockholders financial
Broker Non-Votes financial
independent registered public accounting firm financial
emerging growth company regulatory
proxy statement financial
FAQ
Were Adagio Medical Holdings (ADGM) director nominees elected at the 2026 annual meeting?
How many votes did Adagio Medical director Orly Mishan receive at the 2026 meeting?
How many votes did Adagio Medical director Sean Salmon receive at the 2026 meeting?
Did Adagio Medical Holdings (ADGM) stockholders ratify the independent auditor for 2026?
What proposals were considered at Adagio Medical Holdings (ADGM) 2026 annual meeting?
AI-generated analysis. How Rhea-AI works. Not financial advice.